Spots on lung imaging, usually called pulmonary nodules, are overwhelmingly caused by infections, old scars, or small benign growths rather than cancer. When a CT scan or chest X-ray reveals one, the first reaction is understandable alarm, but the vast majority turn out to be harmless. That said, some nodules do represent early-stage lung cancer or metastatic disease from cancers elsewhere in the body, which is exactly why doctors take every finding seriously and have detailed protocols for deciding which spots deserve further workup and which can safely be watched over time.
Infections Are the Most Common Benign Cause
If you live in or have traveled through certain regions, fungal infections are a leading explanation for a spot on your lung. Histoplasmosis, coccidioidomycosis (valley fever), and blastomycosis can all leave behind small granulomas, essentially little clumps of scar tissue that form when your immune system walls off the infection. These healed granulomas show up as solid, well-defined nodules that can persist on imaging for decades. Mycobacterial infections, including tuberculosis and nontuberculous mycobacteria, produce similar-looking nodules. These infectious granulomas are the single most common benign mimics of lung cancer, and they can even grow over time or light up on advanced metabolic scans in ways that raise further suspicion of malignancy.1Diagnostic Histopathology. Infections that mimic malignancy in the lung
Bacterial pneumonia that has resolved can also leave a residual nodule. In areas where tuberculosis is common, old TB scars are among the most frequent incidental findings on chest imaging. The tricky part is that these infection-related spots don’t always look obviously benign. Some develop irregular edges or increase in size, features normally considered red flags for cancer. This overlap is a recurring theme in lung nodule evaluation and a major reason why a single scan rarely gives a definitive answer.
Inflammatory and Autoimmune Conditions
Chronic inflammatory diseases can produce lung nodules that have nothing to do with infection or cancer. Rheumatoid arthritis is one of the better-known culprits. In a CT study of patients with rheumatoid arthritis, roughly one in five had pulmonary nodules.2PubMed. Lung changes in rheumatoid arthritis: CT findings These rheumatoid nodules are classified as non-infectious inflammatory lesions and can appear as single spots or in clusters.3Journal of Pulmonary Medicine & Respiratory Research. Pulmonary Nodules In Patients With Chronic Rheumatoid Arthritis: An Up-To-Date Review Case reports describe patients with known RA presenting with multiple lung nodules that, after biopsy, turned out to be rheumatoid nodules with no sign of malignancy or infection.4PubMed Central. Rheumatoid Arthritis With Multiple Lung Nodules: A Case Report
Sarcoidosis is another inflammatory condition that commonly affects the lungs. It tends to produce clusters of small nodules, often along the lymphatic pathways in the lung, and can be mistaken for metastatic cancer on initial imaging. Granulomatosis with polyangiitis (formerly called Wegener’s granulomatosis) can create lung nodules that cavitate, meaning they develop hollow centers. For anyone with a known autoimmune condition, a new lung spot should prompt the medical team to consider the underlying disease before assuming something worse.
Benign Tumors
Not all tumors in the lung are cancerous. The most common benign lung tumor is a hamartoma, a slow-growing mass made up of a mixture of cartilage, fat, and other normal tissue components that happened to assemble in the wrong place.5PubMed Central. The clinicopathological challenges of symptomatic and incidental pulmonary hamartomas diagnosis About a third of patients with hamartomas have no symptoms at all; the spot is found incidentally during imaging done for something else entirely. In a study of hamartoma patients, the most common appearance was a solitary pulmonary nodule, with sizes ranging from 6 mm to 100 mm and a mean diameter around 25 mm.6Revista Portuguesa de Pneumologia (English Edition). The frequency of lung cancer in patients with pulmonary hamartomas
A key imaging clue for hamartomas is the presence of fat or “popcorn” calcification inside the nodule, patterns that are quite characteristic and help radiologists feel more confident calling a spot benign without invasive testing.7PubMed. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions Other benign growths that can produce lung spots include pulmonary chondromas, sclerosing pneumocytomas, and inflammatory pseudotumors, though these are all considerably rarer than hamartomas.
Vascular Abnormalities That Look Like Spots
Sometimes what appears to be a lung nodule is actually a blood vessel abnormality. Pulmonary arteriovenous malformations (PAVMs) are abnormal connections between arteries and veins in the lung. On a standard chest X-ray, a PAVM can look like a round spot indistinguishable from a solid nodule.8PubMed. Pulmonary arteriovenous malformations and their mimics CT scanning usually clarifies the diagnosis because you can trace the feeding artery and draining vein, but even on CT, other vascular oddities like pulmonary vein varices, pseudoaneurysms, or collateral vessels from conditions such as fibrosing mediastinitis can mimic both PAVMs and solid nodules.9PubMed. CT Appearance of Pulmonary Arteriovenous Malformations and Mimics Intrapulmonary lymph nodes, which are normal structures, can also show up as small nodules, especially near the lung fissures.
When the Spot Is Cancer
The fear behind every lung spot is lung cancer, and that fear is not unfounded in certain situations. Among primary lung cancers that present as nodules, adenocarcinoma is by far the most common type, accounting for roughly 80 to 90 percent of cancerous nodules across various size categories in one study.10PubMed Central. Primary solid lung cancerous nodules with different sizes: computed tomography features and their variations Squamous cell carcinoma is the second most common, and small cell carcinoma, large cell carcinoma, and carcinoid tumors make up the remainder.
The likelihood that any given nodule is cancerous depends heavily on its size. As diameter increases, so does the probability of malignancy.11PubMed Central. Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology Very small nodules, under 6 mm, are overwhelmingly benign. Larger nodules warrant closer attention. Patient factors also matter: age over 50, a history of smoking, prior cancer, family history of lung cancer, and exposure to substances like asbestos or radon all push the probability higher.
A lung spot can also be a metastasis from a cancer that started somewhere else in the body. Cancers of the breast, colon, kidney, and skin (melanoma) are among the most common to spread to the lungs. Metastatic lung nodules tend to be multiple and round, though a solitary metastasis is possible and can be difficult to distinguish from a primary lung cancer without biopsy.
How Doctors Read the Spot on Imaging
Radiologists use a set of visual features to sort nodules into more or less suspicious categories. Smooth, well-defined margins and small size lean toward a benign diagnosis. Lobulated contours, spiculated (spiky) edges, and distortion of nearby blood vessels lean toward malignancy.7PubMed. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions In a lung cancer screening study, virtually all nodules with smooth margins and polygonal shapes turned out to be benign.12PubMed. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings
Calcification patterns also help. Dense, central, or “popcorn” calcification strongly suggests a benign process like a healed granuloma or hamartoma. Eccentric or stippled calcification is less reassuring. And the presence of fat within a nodule is a reliable marker for hamartoma specifically.7PubMed. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions But there is substantial overlap in how benign and malignant nodules look internally, which is why morphology alone is rarely enough to make a final call on ambiguous spots.
Subsolid and Ground-Glass Nodules
Not all lung spots are solid white dots on a scan. Some appear as hazy, translucent areas called ground-glass nodules, and others are a mix of solid and hazy components called part-solid nodules. Together, these are grouped as subsolid nodules, and they follow a different set of rules from solid spots. Subsolid nodules carry a higher risk of being an indolent, slow-growing malignancy than their solid counterparts, even when they are small. Data from the National Lung Screening Trial found that even subsolid nodules classified into a lower-risk surveillance category had malignancy rates of about 3 percent, which was higher than the expected 1 percent. For nodules bumped into a slightly higher-risk category, the malignancy rate was around 14 percent.13PubMed Central. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial
The silver lining is that most cancers arising from subsolid nodules grow very slowly. Many are early-stage adenocarcinomas that sit quietly for years. This slow pace gives doctors time to monitor them with serial CT scans rather than rushing to biopsy. The challenge is that a small percentage will eventually progress, and figuring out which ones is an active area of research.
PET Scans and Their Limits
When a CT scan raises enough suspicion, doctors often order a PET scan, which works by detecting areas of high metabolic activity. Cancer cells tend to consume more sugar than normal tissue, so they “light up” on PET. In one study, PET achieved a sensitivity of about 69 percent and a specificity of 85 percent for characterizing solitary lung lesions, with overall accuracy similar to CT alone at around 74 percent. For nodules smaller than 10 mm, sensitivity dropped to about 50 percent.14Journal of Nuclear Medicine. Accuracy of PET/CT in Characterization of Solitary Pulmonary Lesions
PET is far from perfect. False positives happen because infections and inflammatory conditions like sarcoidosis or active granulomatous disease also cause high metabolic activity, making benign spots light up just like cancer.15PubMed Central. False positive and false negative FDG-PET scans in various thoracic diseases False negatives are also a concern: slow-growing tumors like some adenocarcinomas, carcinoid tumors, and low-grade lymphomas can have low metabolic activity and fly under the PET radar. In regions where tuberculosis or fungal infections are common, the specificity of PET drops further, to around 61 percent compared with 77 percent in areas without endemic infections.16JAMA. Accuracy of FDG-PET to Diagnose Lung Cancer in Areas With Infectious Lung Disease: A Meta-analysis Where you live can change how useful your PET scan is.
Risk Prediction Models
Doctors don’t just eyeball a nodule and guess. Several validated mathematical models combine patient characteristics and nodule features to estimate the probability that a given spot is malignant. The most widely used are the Mayo Clinic model, the Brock University model, and the Herder model, the latter of which also incorporates PET scan results. In validation studies, the Mayo and Brock models perform similarly, with accuracy metrics in the high range, and the Herder model, by adding PET data, achieves even higher accuracy.17PubMed. Risk of malignancy in pulmonary nodules: A validation study of four prediction models These models are not infallible. Their performance can vary across different populations, and they tend to be somewhat less accurate for very small nodules.18PubMed Central. Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical population Still, they give the clinical team a structured way to move from gut feeling to evidence-based decision-making about whether to watch, scan further, or biopsy.
When a Biopsy Is Needed
If imaging and risk models leave the diagnosis uncertain, a tissue sample is the next step. There are two main approaches. A CT-guided needle biopsy (transthoracic needle aspiration) involves inserting a thin needle through the chest wall directly into the nodule. It tends to have higher sensitivity for malignancy, around 77 percent in one institutional comparison, but carries a higher risk of complications like pneumothorax (a small lung collapse).19PubMed Central. CT-Guided vs. Navigational Bronchoscopic Biopsies for Solitary Pulmonary Nodules: A Single-Institution Retrospective Comparison The alternative is bronchoscopy-based biopsy, often using electromagnetic navigation to reach nodules deep in the lung. A meta-analysis of this technique found a pooled sensitivity around 82 percent with essentially no procedure-related complications reported.20PubMed Central. Meta-analysis of the diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules The choice between the two depends on nodule location, size, and the patient’s overall health.
Not every indeterminate nodule goes straight to biopsy. The Fleischner Society guidelines, last updated in 2017, provide a widely followed framework for deciding when to watch and when to act. The updated guidelines raised the minimum size threshold for follow-up, reflecting evidence that very small solid nodules rarely turn out to be cancer and that repeated scanning of tiny spots does more harm than good through false alarms and unnecessary procedures.21PubMed. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017 The guidelines also emphasize morphology, accurate measurement, and patient risk factors rather than size alone.22PubMed. Updated Fleischner Society Guidelines for Managing Incidental Pulmonary Nodules: Common Questions and Challenging Scenarios
How Often Screening Turns Up False Alarms
If you’ve had a low-dose CT scan for lung cancer screening, there’s a reasonable chance the report mentions at least one nodule. In studies reviewed for the US Preventive Services Task Force, false-positive rates for baseline screening ranged from about 8 percent to nearly 50 percent, depending heavily on how the study defined a “positive” result and what size cutoff they used.23JAMA. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force In other words, a large share of people flagged for additional evaluation after screening turn out not to have cancer. False-positive rates tend to drop with each subsequent screening round, as stable nodules from earlier scans get “cleared” and new findings become more meaningful.
This high false-positive rate is not a flaw in the technology so much as a consequence of how common benign nodules are. Healthy lungs are full of little irregularities, healed infections, and lymph nodes that show up on modern high-resolution scanners. The tradeoff is that screening does catch real cancers early, when they are most treatable, but it also generates a lot of worry over spots that will never cause problems.
The Anxiety of Waiting
Finding out you have a lung spot, even one your doctor says is “probably nothing,” can be psychologically difficult. In a trial that specifically measured emotional responses to newly identified small pulmonary nodules, roughly a third of patients reported at least mild distress, and about 7 percent reported severe distress. Larger nodule size and not being promptly told about the finding by a clinician were both associated with greater emotional upset.24PubMed. Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules: Results From the Watch the Spot Trial Anxiety was also higher among women, younger patients, current or former smokers, and certain racial and ethnic groups. Separate research in patients with incidental nodules found that anxiety was linked to low social support and prior psychological illness, while depression was associated with marital instability and low social support.25PubMed Central. Assessment of anxiety and depression in patients with incidental pulmonary nodules and analysis of its related impact factors
If you’re in the waiting period between scans, it helps to understand that the vast majority of small, incidentally found nodules are benign, and that the watch-and-wait approach exists precisely because the risk of jumping to biopsy or surgery often outweighs the risk of a short delay for something that is almost certainly harmless. Timely communication from your doctor, even just a quick explanation of the plan, meaningfully reduces distress.
What Happens If a Spot Is Cancer
For nodules that do turn out to be early-stage non-small cell lung cancer, surgery is the standard treatment and offers the best long-term survival. A large comparison found that lobectomy (removing the entire lobe containing the tumor) was associated with the greatest reduction in mortality risk, followed by segmentectomy and wedge resection, all of which outperformed stereotactic body radiation therapy (SBRT).26JAMA Network Open. Comparison of Long-term Survival of Patients With Early-Stage Non–Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy SBRT remains an important option for patients who cannot tolerate surgery due to other health problems. The key takeaway is that catching a cancerous nodule while it is still small and localized gives you significantly more treatment options and a much better prognosis than finding it later.
Lung Spots in Children
Adults are not the only ones who get lung nodules. Studies looking at chest CTs performed on children after trauma found that roughly a third to nearly 40 percent had at least one pulmonary nodule. An even higher rate, around 75 percent, was found in children who had chest CTs done before surgery for a chest wall deformity.27PubMed Central. Pediatric pulmonary nodules: current state of knowledge, AI applications, and future directions In children, these nodules are almost always benign and often represent intrapulmonary lymph nodes or tiny areas of scarring. The challenge is that the adult guidelines for nodule management were not designed with children in mind, and applying adult risk frameworks to pediatric patients can lead to unnecessary follow-up imaging and anxiety for families.
Artificial Intelligence as a Second Set of Eyes
AI tools are increasingly being used alongside radiologists to catch nodules that a human reader might miss and to help estimate the probability that a given nodule is malignant. Current AI systems achieve a sensitivity of over 95 percent for detecting nodules on CT, with fewer than one false positive per scan, and their use as a “second reader” has been shown to improve detection accuracy.28PubMed Central. Artificial intelligence in automated detection of lung nodules: a narrative review Deep learning models have also shown promise in risk assessment, particularly for indeterminate nodules where the standard prediction models struggle. In one analysis, an AI model substantially reduced false positives compared to a widely used clinical calculator, classifying about 68 percent of benign nodules as low risk versus roughly 47 percent with the conventional tool. That kind of improvement translates directly into fewer unnecessary biopsies and follow-up scans for people whose spots were never dangerous in the first place.
Imaging Artifacts and Non-Nodule Mimics
Before assuming a spot on your lung image is a real finding, it’s worth knowing that artifacts and technical quirks can create phantom nodules. ECG monitoring leads placed on the chest during a scan can cast shadows that mimic pulmonary nodules on a chest X-ray.29Chest. Pulmonary Nodule Mimicked by ECG Lead Artifact Nipple shadows, skin lesions like moles or warts, and even bone islands in the ribs can all project over the lung fields and be misread as nodules on plain X-rays. CT scans are much better at distinguishing real nodules from these imposters, which is one reason that a chest X-ray finding of a “possible nodule” often leads to a follow-up CT for confirmation rather than immediate concern. Breathing artifacts, where slight motion during the scan blurs the image, can also create or obscure apparent nodules. If your report mentions a questionable finding, a repeat scan with careful breath-holding instructions may clear it up entirely.